UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Mammalian artificial chromosomes and clinical applications for genetic modification of stem cells: an overview

Methods in molecular biology (Clifton, N.J.), 2011-01, Vol.738, p.199

2011

Volltextzugriff (PDF)

Transgene expression after stable transfer of a mammalian artificial chromosome into human hematopoietic cells

Experimental hematology, 2005-12, Vol.33 (12), p.1470-1476

2005

Volltextzugriff (PDF)

346. The ACE System, a Mammalian Artificial Chromosome Engineering Technology: Delivery and Transgene Expression in Human Adult & Embryonic Stem Cells

Molecular therapy, 2006-05, Vol.13 (S1), p.S132-S132

2006

Volltextzugriff (PDF)

Risk management for the biotechnology industry: A Canadian perspective

Journal of commercial biotechnology, 2008-04, Vol.14 (2), p.128-140

2008

Volltextzugriff (PDF)

Critical success factors for biotechnology industry in Canada

Journal of commercial biotechnology, 2007-02, Vol.13 (2), p.68-77

2007

Volltextzugriff (PDF)

Transfer and Stable Transgene Expression of a Mammalian Artificial Chromosome into Bone Marrow‐Derived Human Mesenchymal Stem Cells

Stem cells (Dayton, Ohio), 2004-01, Vol.22 (3), p.324-333

2004

Volltextzugriff (PDF)

Risk management for the biotechnology industry: A Canadian perspective

Journal of commercial biotechnology, 2008-04, Vol.14 (2)

2008

Volltextzugriff (PDF)

Risk management for the biotechnology industry: A Canadian perspective

Journal of commercial biotechnology, 2008-04, Vol.14 (2), p.128-140

2008

Volltextzugriff (PDF)

A novel approach for gene therapy: engraftment of fibroblasts containing the artificial chromosome expression system at the site of inflammation

The journal of gene medicine, 2006-01, Vol.8 (1), p.63-71

2006

Volltextzugriff (PDF)

476. Human Mesenchymal Stem Cells Genetically Modified To Express High Levels of Erythropoietin Through Transfer of an Artificial Chromosome Engineered Using the ACE System

Molecular therapy, 2004-05, Vol.9 (S1), p.S181-S181

2004

Volltextzugriff (PDF)

Transgene Expression after Stable Transfer of a Mammalian Artificial Chromosome into Human Hematopoietic Cells

Blood, 2004-11, Vol.104 (11), p.498-498

2004

Volltextzugriff (PDF)

A flow cytometry technique for measuring chromosome‐mediated gene transfer

Cytometry (New York, N.Y.), 2001-06, Vol.44 (2), p.100-105

2001

Volltextzugriff (PDF)

Increase in the fraction of necrotic, not apoptotic, cells in SiHa xenograft tumours shortly after irradiation

Radiotherapy and oncology, 1999, Vol.50 (1), p.113-119

1999

Volltextzugriff (PDF)

Schedule Dependence for Cisplatin and Etoposide Multifraction Treatments of Spheroids

JNCI : Journal of the National Cancer Institute, 1990-12, Vol.82 (23), p.1841-1845

1990

Volltextzugriff (PDF)

Sequencing radiation and adriamycin exposures in spheroids to maximize therapeutic gain

International journal of radiation oncology, biology, physics, 1989-08, Vol.17 (2), p.345-350

1989

Volltextzugriff (PDF)

Critical success factors for biotechnology industry in Canada

Journal of commercial biotechnology, 1969-12, Vol.13 (2)

1969

Volltextzugriff (PDF)

Tumor resistance to therapy: a genetic or kinetic problem?

Cancer communications (New York), 1989, Vol.1 (5), p.277

1989

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Mammalian artificial chromosomes and clinical applications for genetic modification of stem cells: an overview

Transgene expression after stable transfer of a mammalian artificial chromosome into human hematopoietic cells

346. The ACE System, a Mammalian Artificial Chromosome Engineering Technology: Delivery and Transgene Expression in Human Adult & Embryonic Stem Cells

Risk management for the biotechnology industry: A Canadian perspective

Critical success factors for biotechnology industry in Canada

Transfer and Stable Transgene Expression of a Mammalian Artificial Chromosome into Bone Marrow‐Derived Human Mesenchymal Stem Cells

Risk management for the biotechnology industry: A Canadian perspective

Risk management for the biotechnology industry: A Canadian perspective

A novel approach for gene therapy: engraftment of fibroblasts containing the artificial chromosome expression system at the site of inflammation

476. Human Mesenchymal Stem Cells Genetically Modified To Express High Levels of Erythropoietin Through Transfer of an Artificial Chromosome Engineered Using the ACE System

Transgene Expression after Stable Transfer of a Mammalian Artificial Chromosome into Human Hematopoietic Cells

A flow cytometry technique for measuring chromosome‐mediated gene transfer

Increase in the fraction of necrotic, not apoptotic, cells in SiHa xenograft tumours shortly after irradiation

Schedule Dependence for Cisplatin and Etoposide Multifraction Treatments of Spheroids

Sequencing radiation and adriamycin exposures in spheroids to maximize therapeutic gain

Critical success factors for biotechnology industry in Canada

Tumor resistance to therapy: a genetic or kinetic problem?

Suchergebnisse filtern